DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0090-9556/04/3207-707-714$20.00
DMD 32:707-714, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ashino, T.
Right arrow Articles by Yoshida, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashino, T.
Right arrow Articles by Yoshida, T.

INVOLVEMENT OF INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR {alpha} IN CYP3A11 AND 2C29 DOWN-REGULATION BY BACILLUS CALMETTE-GUÉRIN AND LIPOPOLYSACCHARIDE IN MOUSE LIVER

Takashi Ashino, Takiko Oguro, Seiji Shioda, Reiko Horai, Masahide Asano, Kenji Sekikawa, Yoichiro Iwakura, Satoshi Numazawa, and Takemi Yoshida

Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University, Tokyo, Japan (T.A., S.N., T.Y); Japan Development, R&D Alcon Research, Ltd., Fort Worth, Texas (T.O.); Department of Anatomy, School of Medicine, Showa University, Tokyo, Japan (S.S.); Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan (R.H., Y.I.); Department of Transgenic Animal Science, Graduate School of Medical Science, Kanazawa University, Ishikawa, Japan (M.A.); and Department of Molecular Biology and Immunology, National Institute of Agrobiological Sciences, Ibaraki, Japan (K.S.)

Bacillus Calmette-Guérin (BCG) and lipopolysaccharide (LPS) are well known potent activators of the cell-mediated immune system and thus lead to the decreases in cytochrome P450 (P450). In this study we used interleukin (IL)-1{alpha}/ß, IL-6, or tumor necrosis factor {alpha} (TNF{alpha}) knockout (KO) mice to investigate how each cytokine is involved in P450 down-regulation, especially CYP3A11 and 2C29. BCG (40 mg/kg) was found to reduce both CYP3A11 and 2C29 mRNAs at 24 h after treatment in IL-1{alpha} KO mice in a manner similar to that seen in wild-type mice. CYP3A11 mRNA, but not CYP2C29 mRNA, was significantly decreased by BCG treatment in the TNF{alpha} KO mice, although the decrease was less than that of wild-type or IL-1{alpha}/ß KO mice. In contrast, BCG showed no significant effect on CYP3A11 and 2C29 mRNAs in IL-6 KO mice. On the other hand, LPS was able to decrease CYP3A11 and 2C29 mRNA levels in all of the cytokine KO mice and markedly increased systemic levels of TNF{alpha}; BCG (40 mg/kg) lacked such activity. The present study has shown that IL-6 and TNF{alpha} are likely to be major factors involved in the down-regulation of CYP3A11 and 2C29 mRNAs in mice. In addition, there exist differences in the amount and/or kind of cytokines released by BCG or LPS, the latter being more potent than the former. This will be a possible reason for differential capability of P450 down-regulation between BCG and LPS.


Address correspondence to: Takemi Yoshida, Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555. E-mail: yoshida{at}pharm.showa-u.ac.jp




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
A. E. Aitken and E. T. Morgan
Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes
Drug Metab. Dispos., September 1, 2007; 35(9): 1687 - 1693.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. Lee, J. R. Hutson, V. K.-F. Tzau, and D. S. Riddick
Regulation of Constitutive Mouse Hepatic Cytochromes P450 and Growth Hormone Signaling Components by 3-Methylcholanthrene
Drug Metab. Dispos., September 1, 2006; 34(9): 1530 - 1538.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. A. Richardson and E. T. Morgan
Hepatic Cytochrome P450 Gene Regulation during Endotoxin-Induced Inflammation in Nuclear Receptor Knockout Mice
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 703 - 709.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.